A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours
about
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicinePolymeric conjugates for drug deliveryPolymer conjugates as anticancer nanomedicines.Cancer therapies utilizing the camptothecins: a review of the in vivo literatureCorrelating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle.Advances of cancer therapy by nanotechnology.Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.
P2860
Q28391849-265A812C-4979-403E-BB0F-7ADDC1F14B21Q36029175-63E32CAC-DDE4-47F3-AB39-D04C1422535CQ36561667-1069484C-8492-45E6-8EEE-04874DD0AC84Q37069556-49D2A8DF-FE7C-43C8-A0CA-A170F6AF819FQ37173162-6E6EC346-BA0E-4E26-8875-D55A92F30BA4Q37234202-BDAB33EB-6ABC-4287-B5D2-0043BD113009Q37394856-D6CD42EB-E5EB-488A-B7C4-44C8FA5E078EQ38075544-526BA55E-1D8F-44C5-AEB2-78C8B03011A0
P2860
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A phase I study with MAG-campt ...... lt patients with solid tumours
@ast
A phase I study with MAG-campt ...... lt patients with solid tumours
@en
type
label
A phase I study with MAG-campt ...... lt patients with solid tumours
@ast
A phase I study with MAG-campt ...... lt patients with solid tumours
@en
prefLabel
A phase I study with MAG-campt ...... lt patients with solid tumours
@ast
A phase I study with MAG-campt ...... lt patients with solid tumours
@en
P2093
P2860
P356
P1476
A phase I study with MAG-campt ...... lt patients with solid tumours
@en
P2093
A T van Oosterom
F M Wachters
H J M Groen
J G Maring
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601811
P407
P577
2004-06-01T00:00:00Z